The number of cases is lower than the nearly 400 CM cases microbiologically confirmed annually in Botswana without CrAg screening2; however, a proportion of patients will be diagnosed and hospitalized with CM without recent CD4 testing. This evidence concerns the gene CD4 and cutaneous mastocytosis.